Stay updated on Pyrotinib Plus Vinorelbine in HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pyrotinib Plus Vinorelbine in HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pyrotinib Plus Vinorelbine in HER2+ Breast Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The history now displays Revision: v3.3.3 in the footer. The items 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' have been removed.
    Difference
    0.2%
    Check dated 2025-12-23T08:44:45.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Version history shows the addition of revision v3.3.2 and the removal of v3.2.0 in the record history for NCT03997539. These changes are administrative and do not alter study content, eligibility criteria, outcomes, or timelines. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T17:39:50.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The government funding notice has been removed from the page, and the rest of the content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.8%
    Check dated 2025-11-17T17:23:35.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Version history shows no changes between the captured screenshots; the Changes field for Version 1 is 'None'.
    Difference
    0.1%
    Check dated 2025-11-03T09:53:34.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    Added a government funding status notice and updated version to v3.2.0; removed the previous v3.1.0 reference.
    Difference
    13%
    Check dated 2025-10-05T14:29:23.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    Version bump from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.3%
    Check dated 2025-09-28T09:46:51.000Z thumbnail image

Stay in the know with updates to Pyrotinib Plus Vinorelbine in HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pyrotinib Plus Vinorelbine in HER2+ Breast Cancer Clinical Trial page.